HO-3867

CAS No. 1172133-28-6

HO-3867 ( HO 3867;HO3867 )

Catalog No. M10576 CAS No. 1172133-28-6

A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 63 Get Quote
5MG 87 Get Quote
10MG 115 Get Quote
25MG 237 Get Quote
50MG 380 Get Quote
100MG 605 Get Quote
200MG 843 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    HO-3867
  • Note
    Research use only, not for human use.
  • Brief Description
    A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.
  • Description
    A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs; induces G2-M cell cycle arrest in A2780 cells by modulating cell cycle regulatory molecules p53, p21, p27, CDK 2, and cyclin, and promotes apoptosis, inhibits pSTAT3 (Tyr705 and Ser727) and JAK1 and increases apoptotic markers cleaved caspase-3 and PARP in xenograft tumor tissues.
  • Synonyms
    HO 3867;HO3867
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1172133-28-6
  • Formula Weight
    464.55
  • Molecular Formula
    C28H30F2N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 32 mg/mL
  • SMILES
    O=C1/C(CN(CC2=CC(C)(C)N(O)C2(C)C)C/C1=C\C3=CC=C(F)C=C3)=C/C4=CC=C(F)C=C4
  • Chemical Name
    4-Piperidinone, 1-[(2,5-dihydro-1-hydroxy-2,2,5,5-tetramethyl-1H-pyrrol-3-yl)methyl]-3,5-bis[(4-fluorophenyl)methylene]-, (3E,5E)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rath KS, et al. Cancer Res. 2014 Apr 15;74(8):2316-27.
2. Selvendiran K, et al. Mol Cancer Ther. 2010 May;9(5):1169-79.
3. Selvendiran K, et al. Cancer Biol Ther. 2011 Nov 1;12(9):837-45.
molnova catalog
related products
  • LLL3

    LLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor.

  • HJC0152

    A potent, orally bioavailable STAT3 signaling inhibitor that exhibits promising antitumor effects in vitro and in vivo.

  • BP-5-087

    A potent, selective STAT3 SH2 domain inhibitor (EC50=5.6 uM) that reduces STAT3 phosphorylation and nuclear transactivation.